Monopar Therapeutics (MNPR)

CIK 1645469 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Monopar Therapeutics.

Recent SEC filings

FiledFormAccession number
Nov 4, 202640001437749-26-035040
Nov 4, 202640001437749-26-035039
Oct 27, 2026SCHEDULE 13G0002012383-26-003819
Oct 20, 202640001437749-26-033024
Oct 5, 202640001437749-26-032048
Oct 2, 202640001437749-26-031927
Oct 2, 202640001437749-26-031925
Oct 2, 202640001437749-26-031924
Oct 1, 20261440001950047-26-009981
Sep 28, 202640001437749-26-031411
Sep 24, 20261440001950047-26-009797
Aug 28, 20264/A0001437749-26-029235
Aug 28, 20264/A0001437749-26-029228
Aug 27, 202640001437749-26-029121
Aug 27, 202640001437749-26-029115
Aug 27, 202640001437749-26-029116
Aug 26, 20261440001950047-26-008721
Aug 26, 20261440001950047-26-008724
Aug 25, 20261440001950047-26-008691
Aug 12, 20268-K0001437749-26-027165
Aug 12, 2026SCHEDULE 13G/A0000919574-26-004969
Aug 12, 202610-Q0001437749-26-027164
Aug 12, 2026SCHEDULE 13G/A0002060757-26-000047
Jul 22, 20268-K0001437749-26-024041
Jul 22, 2026S-8 POS0001437749-26-024130